Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | -7.140% | - | - | - | - | - | - |
Promis Neurosciences Inc. | 3.610% | 1.775% | -0.578% | -70.345% | 72.864% | -77.949% | -82.083% |
InMed Pharmaceuticals Inc. | -2.100% | 5.896% | -23.191% | -78.964% | -32.122% | -99.678% | -99.904% |
Resverlogix Corp | - | -1.351% | 0.000% | -60.753% | -15.116% | -93.917% | -98.608% |
News
EnWave Signs Technology Evaluation and License Option Agreement with Food Company Led by Michelin Star Chef
Vancouver, B.C., April 2nd, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that it has signed a Technology Evaluation and License Option Agreement
EnWave Declares Significant Sales Wins for Royalty-Partner BranchOut Food
Vancouver, B.C., February 29th, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that BranchOut Food Inc. (NASDAQ:BOF) (“BranchOut”), a royalty
EnWave Signs Royalty-Bearing Commercial License with Established South American Food Manufacturer
Vancouver, B.C., February 28th, 2024 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a new royalty-bearing commercial